CHM chimeric therapeutics limited

So, according to the latest known timeline (not the one on the...

  1. 8,333 Posts.
    lightbulb Created with Sketch. 3663
    So, according to the latest known timeline (not the one on the website), there is a preclinical study ongoing - CHM 2301. Its an Allogeneic CDH17 CORE-NK study - a CAR-NK therapy (I assume) targeting CDH17


    https://hotcopper.com.au/data/attachments/6463/6463209-ec4a15895849cfbede73d325a3e9c52a.jpg

    ... and yes the team need to update the website.... and yes the preclinical data is stellar for Auto CAR T
    Last edited by Shellbell: 16/09/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.